APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preterm Birth Prevention and Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Preterm Birth Prevention and Treatment Market Analysis and Forecast 2026-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchPreterm Birth Prevention and Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Preterm Birth Prevention and Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Preterm Birth Prevention and Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preterm Birth Prevention and Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Preterm Birth Prevention and Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Preterm Birth Prevention and Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Preterm Birth Prevention and Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Preterm Birth Prevention and Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Preterm Birth Prevention and Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Preterm Birth Prevention and Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Preterm Birth Prevention and Treatment include Teva, Sanofi, Novartis, Merck & Co, Pfizer, Bayer, AbbVie, Viatris and Ferring Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Preterm Birth Prevention and Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Preterm Birth Prevention and Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Preterm Birth Prevention and Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Preterm Birth Prevention and Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Preterm Birth Prevention and Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Preterm Birth Prevention and Treatment revenue, projected growth trends, production technology, application and end-user industry.

Preterm Birth Prevention and Treatment Segment by Company

Teva

Sanofi

Novartis

Merck & Co

Pfizer

Bayer

AbbVie

Viatris

Ferring Pharmaceutical

Aurobindo Pharma

AMAG Pharmaceuticals

Allergan

Preterm Birth Prevention and Treatment Segment by Type

Progesterone Therapy

Tocolytics Therapy

Corticosteroid Therapy

Magnesium Sulfate Therapy

Antihypertensive Therapy

Other

Preterm Birth Prevention and Treatment Segment by Application

Hospital

Drugs Stores

Other

Preterm Birth Prevention and Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preterm Birth Prevention and Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preterm Birth Prevention and Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preterm Birth Prevention and Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Preterm Birth Prevention and Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Preterm Birth Prevention and Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preterm Birth Prevention and Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Progesterone Therapy Major Player Table 3. Tocolytics Therapy Major Player Table 4. Corticosteroid Therapy Major Player Table 5. Magnesium Sulfate Therapy Major Player Table 6. Antihypertensive Therapy Major Player Table 7. Other Major Player Table 8. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Player Table 10. Drugs Stores Major Player Table 11. Other Major Player Table 12. Preterm Birth Prevention and Treatment Industry Trends Table 13. Preterm Birth Prevention and Treatment Industry Drivers Table 14. Preterm Birth Prevention and Treatment Industry Opportunities and Challenges Table 15. Preterm Birth Prevention and Treatment Industry Restraints Table 16. Global Preterm Birth Prevention and Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Preterm Birth Prevention and Treatment Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Preterm Birth Prevention and Treatment Market Share by Region (2021-2026) Table 19. Global Preterm Birth Prevention and Treatment Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Preterm Birth Prevention and Treatment Market Share by Region (2027-2032) Table 21. Global Preterm Birth Prevention and Treatment Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2021-2026) Table 23. Global Preterm Birth Prevention and Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Preterm Birth Prevention and Treatment Key Players Headquarters & Area Served Table 25. Global Preterm Birth Prevention and Treatment Players, Product Type & Application Table 26. Global Preterm Birth Prevention and Treatment Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Preterm Birth Prevention and Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Preterm Birth Prevention and Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Preterm Birth Prevention and Treatment Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Preterm Birth Prevention and Treatment Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2021-2026) Table 33. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2027-2032) Table 34. Global Preterm Birth Prevention and Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Preterm Birth Prevention and Treatment Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Preterm Birth Prevention and Treatment Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2021-2026) Table 38. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2027-2032) Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Preterm Birth Prevention and Treatment Product Portfolio Table 43. Teva Recent Development Table 44. Sanofi Company Information Table 45. Sanofi Business Overview Table 46. Sanofi Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sanofi Preterm Birth Prevention and Treatment Product Portfolio Table 48. Sanofi Recent Development Table 49. Novartis Company Information Table 50. Novartis Business Overview Table 51. Novartis Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Novartis Preterm Birth Prevention and Treatment Product Portfolio Table 53. Novartis Recent Development Table 54. Merck & Co Company Information Table 55. Merck & Co Business Overview Table 56. Merck & Co Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Merck & Co Preterm Birth Prevention and Treatment Product Portfolio Table 58. Merck & Co Recent Development Table 59. Pfizer Company Information Table 60. Pfizer Business Overview Table 61. Pfizer Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Pfizer Preterm Birth Prevention and Treatment Product Portfolio Table 63. Pfizer Recent Development Table 64. Bayer Company Information Table 65. Bayer Business Overview Table 66. Bayer Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Bayer Preterm Birth Prevention and Treatment Product Portfolio Table 68. Bayer Recent Development Table 69. AbbVie Company Information Table 70. AbbVie Business Overview Table 71. AbbVie Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. AbbVie Preterm Birth Prevention and Treatment Product Portfolio Table 73. AbbVie Recent Development Table 74. Viatris Company Information Table 75. Viatris Business Overview Table 76. Viatris Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Viatris Preterm Birth Prevention and Treatment Product Portfolio Table 78. Viatris Recent Development Table 79. Ferring Pharmaceutical Company Information Table 80. Ferring Pharmaceutical Business Overview Table 81. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product Portfolio Table 83. Ferring Pharmaceutical Recent Development Table 84. Aurobindo Pharma Company Information Table 85. Aurobindo Pharma Business Overview Table 86. Aurobindo Pharma Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Aurobindo Pharma Preterm Birth Prevention and Treatment Product Portfolio Table 88. Aurobindo Pharma Recent Development Table 89. AMAG Pharmaceuticals Company Information Table 90. AMAG Pharmaceuticals Business Overview Table 91. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product Portfolio Table 93. AMAG Pharmaceuticals Recent Development Table 94. Allergan Company Information Table 95. Allergan Business Overview Table 96. Allergan Preterm Birth Prevention and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Allergan Preterm Birth Prevention and Treatment Product Portfolio Table 98. Allergan Recent Development Table 99. North America Preterm Birth Prevention and Treatment Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Preterm Birth Prevention and Treatment Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Preterm Birth Prevention and Treatment Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Preterm Birth Prevention and Treatment Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Preterm Birth Prevention and Treatment Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Preterm Birth Prevention and Treatment Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Preterm Birth Prevention and Treatment Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Preterm Birth Prevention and Treatment Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Preterm Birth Prevention and Treatment Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Preterm Birth Prevention and Treatment Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Preterm Birth Prevention and Treatment Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Preterm Birth Prevention and Treatment Revenue by Country (US$ Million) & (2027-2032) Table 113. China Preterm Birth Prevention and Treatment Revenue by Type (2021-2026) & (US$ Million) Table 114. China Preterm Birth Prevention and Treatment Revenue by Type (2027-2032) & (US$ Million) Table 115. China Preterm Birth Prevention and Treatment Revenue by Application (2021-2026) & (US$ Million) Table 116. China Preterm Birth Prevention and Treatment Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Preterm Birth Prevention and Treatment Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Preterm Birth Prevention and Treatment Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Preterm Birth Prevention and Treatment Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Preterm Birth Prevention and Treatment Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Preterm Birth Prevention and Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Preterm Birth Prevention and Treatment Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Preterm Birth Prevention and Treatment Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Preterm Birth Prevention and Treatment Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Preterm Birth Prevention and Treatment Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Preterm Birth Prevention and Treatment Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Preterm Birth Prevention and Treatment Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Preterm Birth Prevention and Treatment Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Preterm Birth Prevention and Treatment Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Preterm Birth Prevention and Treatment Image Figure 2. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preterm Birth Prevention and Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Progesterone Therapy Image Figure 5. Tocolytics Therapy Image Figure 6. Corticosteroid Therapy Image Figure 7. Magnesium Sulfate Therapy Image Figure 8. Antihypertensive Therapy Image Figure 9. Other Image Figure 10. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Preterm Birth Prevention and Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Drugs Stores Image Figure 14. Other Image Figure 15. Global Preterm Birth Prevention and Treatment Market Size (US$ Million) & (2021-2032) Figure 16. Global Preterm Birth Prevention and Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Preterm Birth Prevention and Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Preterm Birth Prevention and Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Preterm Birth Prevention and Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Preterm Birth Prevention and Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Preterm Birth Prevention and Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Preterm Birth Prevention and Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032) Figure 28. North America Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032) Figure 29. North America Preterm Birth Prevention and Treatment Revenue Share by Country (2021-2032) Figure 30. United States Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Preterm Birth Prevention and Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032) Figure 35. Europe Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032) Figure 36. Europe Preterm Birth Prevention and Treatment Revenue Share by Country (2021-2032) Figure 37. Germany Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Preterm Birth Prevention and Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032) Figure 47. China Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Preterm Birth Prevention and Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032) Figure 50. Asia Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032) Figure 51. Asia Preterm Birth Prevention and Treatment Revenue Share by Region (2021-2032) Figure 52. Japan Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Preterm Birth Prevention and Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032) Figure 60. SAMEA Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032) Figure 61. SAMEA Preterm Birth Prevention and Treatment Revenue Share by Country (2021-2032) Figure 62. Brazil Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Preterm Birth Prevention and Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Progesterone Therapy
  • Tocolytics Therapy
  • Corticosteroid Therapy
  • Magnesium Sulfate Therapy
  • Antihypertensive Therapy
  • Other
Applications
  • Hospital
  • Drugs Stores
  • Other
Companies covered
  • Teva
  • Sanofi
  • Novartis
  • Merck & Co
  • Pfizer
  • Bayer
  • AbbVie
  • Viatris
  • Ferring Pharmaceutical
  • Aurobindo Pharma
  • AMAG Pharmaceuticals
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Preterm Birth Prevention and Treatment Market by Type
  3. 1.2.1 Global Preterm Birth Prevention and Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Progesterone Therapy
  5. 1.2.3 Tocolytics Therapy
  6. 1.2.4 Corticosteroid Therapy
  7. 1.2.5 Magnesium Sulfate Therapy
  8. 1.2.6 Antihypertensive Therapy
  9. 1.2.7 Other
  10. 1.3 Preterm Birth Prevention and Treatment Market by Application
  11. 1.3.1 Global Preterm Birth Prevention and Treatment Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Drugs Stores
  14. 1.3.4 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Preterm Birth Prevention and Treatment Market Dynamics
  1. 2.1 Preterm Birth Prevention and Treatment Industry Trends
  2. 2.2 Preterm Birth Prevention and Treatment Industry Drivers
  3. 2.3 Preterm Birth Prevention and Treatment Industry Opportunities and Challenges
  4. 2.4 Preterm Birth Prevention and Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Preterm Birth Prevention and Treatment Market Perspective (2021-2032)
  2. 3.2 Global Preterm Birth Prevention and Treatment Growth Trends by Region
  3. 3.2.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Preterm Birth Prevention and Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Preterm Birth Prevention and Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Preterm Birth Prevention and Treatment Revenue by Players
  2. 4.1.1 Global Preterm Birth Prevention and Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Preterm Birth Prevention and Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Preterm Birth Prevention and Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Preterm Birth Prevention and Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Preterm Birth Prevention and Treatment Players, Product Type & Application
  8. 4.5 Global Preterm Birth Prevention and Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Preterm Birth Prevention and Treatment Market CR5 and HHI
  11. 4.6.3 2025 Preterm Birth Prevention and Treatment Tier 1, Tier 2, and Tier 3
5 Preterm Birth Prevention and Treatment Market Size by Type
  1. 5.1 Global Preterm Birth Prevention and Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Preterm Birth Prevention and Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2021-2032)
6 Preterm Birth Prevention and Treatment Market Size by Application
  1. 6.1 Global Preterm Birth Prevention and Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Preterm Birth Prevention and Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Preterm Birth Prevention and Treatment Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Preterm Birth Prevention and Treatment Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Preterm Birth Prevention and Treatment Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Merck & Co
  20. 7.4.1 Merck & Co Company Information
  21. 7.4.2 Merck & Co Business Overview
  22. 7.4.3 Merck & Co Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co Preterm Birth Prevention and Treatment Product Portfolio
  24. 7.4.5 Merck & Co Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Preterm Birth Prevention and Treatment Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Preterm Birth Prevention and Treatment Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 AbbVie
  38. 7.7.1 AbbVie Company Information
  39. 7.7.2 AbbVie Business Overview
  40. 7.7.3 AbbVie Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AbbVie Preterm Birth Prevention and Treatment Product Portfolio
  42. 7.7.5 AbbVie Recent Developments
  43. 7.8 Viatris
  44. 7.8.1 Viatris Company Information
  45. 7.8.2 Viatris Business Overview
  46. 7.8.3 Viatris Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Viatris Preterm Birth Prevention and Treatment Product Portfolio
  48. 7.8.5 Viatris Recent Developments
  49. 7.9 Ferring Pharmaceutical
  50. 7.9.1 Ferring Pharmaceutical Company Information
  51. 7.9.2 Ferring Pharmaceutical Business Overview
  52. 7.9.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product Portfolio
  54. 7.9.5 Ferring Pharmaceutical Recent Developments
  55. 7.10 Aurobindo Pharma
  56. 7.10.1 Aurobindo Pharma Company Information
  57. 7.10.2 Aurobindo Pharma Business Overview
  58. 7.10.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Aurobindo Pharma Preterm Birth Prevention and Treatment Product Portfolio
  60. 7.10.5 Aurobindo Pharma Recent Developments
  61. 7.11 AMAG Pharmaceuticals
  62. 7.11.1 AMAG Pharmaceuticals Company Information
  63. 7.11.2 AMAG Pharmaceuticals Business Overview
  64. 7.11.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product Portfolio
  66. 7.11.5 AMAG Pharmaceuticals Recent Developments
  67. 7.12 Allergan
  68. 7.12.1 Allergan Company Information
  69. 7.12.2 Allergan Business Overview
  70. 7.12.3 Allergan Preterm Birth Prevention and Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Allergan Preterm Birth Prevention and Treatment Product Portfolio
  72. 7.12.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Preterm Birth Prevention and Treatment Revenue (2021-2032)
  2. 8.2 North America Preterm Birth Prevention and Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Preterm Birth Prevention and Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Preterm Birth Prevention and Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Preterm Birth Prevention and Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Preterm Birth Prevention and Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Preterm Birth Prevention and Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Preterm Birth Prevention and Treatment Revenue by Country
  11. 8.6.1 North America Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Preterm Birth Prevention and Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Preterm Birth Prevention and Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Preterm Birth Prevention and Treatment Revenue (2021-2032)
  2. 9.2 Europe Preterm Birth Prevention and Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Preterm Birth Prevention and Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Preterm Birth Prevention and Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Preterm Birth Prevention and Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Preterm Birth Prevention and Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Preterm Birth Prevention and Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Preterm Birth Prevention and Treatment Revenue by Country
  11. 9.6.1 Europe Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Preterm Birth Prevention and Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Preterm Birth Prevention and Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Preterm Birth Prevention and Treatment Revenue (2021-2032)
  2. 10.2 China Preterm Birth Prevention and Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Preterm Birth Prevention and Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Preterm Birth Prevention and Treatment Revenue by Type (2027-2032)
  5. 10.3 China Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Preterm Birth Prevention and Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Preterm Birth Prevention and Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Preterm Birth Prevention and Treatment Revenue by Application (2027-2032)
  9. 10.5 China Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Preterm Birth Prevention and Treatment Revenue (2021-2032)
  2. 11.2 Asia Preterm Birth Prevention and Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Preterm Birth Prevention and Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Preterm Birth Prevention and Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Preterm Birth Prevention and Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Preterm Birth Prevention and Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Preterm Birth Prevention and Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Preterm Birth Prevention and Treatment Revenue by Country
  11. 11.6.1 Asia Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Preterm Birth Prevention and Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Preterm Birth Prevention and Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Preterm Birth Prevention and Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Preterm Birth Prevention and Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Preterm Birth Prevention and Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Preterm Birth Prevention and Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Preterm Birth Prevention and Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Preterm Birth Prevention and Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Preterm Birth Prevention and Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Preterm Birth Prevention and Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Preterm Birth Prevention and Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Preterm Birth Prevention and Treatment Revenue by Country
  11. 12.6.1 SAMEA Preterm Birth Prevention and Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Preterm Birth Prevention and Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Preterm Birth Prevention and Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst